Results 221 to 230 of about 1,017,020 (303)

Prognostic Determinants of Overall Survival After Resection for Pancreatic Ductal Adenocarcinoma: A Consensus‐Based Conceptual Framework

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Pancreatic ductal adenocarcinoma (PDAC) carries a dismal prognosis despite surgical resection, yet the prognostic literature remains fragmented across hundreds of single‐institution studies that vary in design, covariates, and analytical approaches.
Muhammad Maisam Ali   +8 more
wiley   +1 more source

Retrohepatic Vena Cava Encirclement, as Surrogate of Extensive Liver Manipulation During Caval Sparing Hepatectomy, Is a Risk Factor for Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Introduction In liver transplantation (LT) with a caval sparing (CS) approach, the presence of complete encirclement of inferior vena cava (IVC‐E) by hypertrophic segment 1 increases the technical complexity of hepatectomy. Thus, in LT for hepatocellular carcinoma (HCC), It may be suspected that the resulting greater liver manipulation and ...
Riccardo Pravisani   +9 more
wiley   +1 more source

Rethinking Age Limits in Oncoplastic Breast Surgery: Long‐Term Outcomes of Oncoplastic Surgery in Elderly Patients

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Methods Although OBS is a well‐established approach, evidence regarding its long‐term safety and outcomes in older women remains limited. We performed a retrospective analysis to identify patients ≥ 60 years who underwent OBS for breast cancer between 2001 and 2014.
Francesca De Lorenzi   +9 more
wiley   +1 more source

EUS‐Guided Hepaticogastrostomy Using a Novel Ultra‐Tapered Bougie Dilator for Effective Bile Aspiration During Tract Dilation

open access: yes
Journal of Hepato-Biliary-Pancreatic Sciences, EarlyView.
Shuntaro Mukai   +9 more
wiley   +1 more source

Treatment Response and Oncologic Outcomes Following Neoadjuvant Chemotherapy Switch in Localized Pancreatic Ductal Adenocarcinoma

open access: yesJournal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives Many patients undergoing neoadjuvant therapy for localized pancreatic ductal adenocarcinoma (PDAC) experience treatment intolerance or disease progression during initial therapy. Although chemotherapy switch is increasingly utilized, response rates and oncologic outcomes remain poorly defined.
Galen C. Gist   +14 more
wiley   +1 more source

Case report of invasive ductal carcinoma of the breast in a Pakistani male aged 55. [PDF]

open access: yesDiscov Oncol
Aziz S   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy